Legend Biotech Corporation (FRA:9LB)
Germany · Delayed Price · Currency is EUR 20.40
-0.20 (-0.97%)
Last updated: Apr 24, 2026, 8:10 AM CET
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of €3.79 billion as of April 23, 2026. Its market cap has decreased by -25.51% in one year.
Market Cap
3.79B
Enterprise Value
3.33B
Revenue
876.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€20.40
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has decreased from 4.23B to 3.79B, a decrease of -10.43%. That is a compound annual growth rate of -1.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 4.09B | 19.66% |
| Dec 31, 2025 | 3.42B | -40.69% |
| Dec 31, 2024 | 5.77B | -41.73% |
| Dec 29, 2023 | 9.90B | 26.55% |
| Dec 30, 2022 | 7.82B | 23.93% |
| Dec 31, 2021 | 6.31B | 106.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 49.36M |
| Biomark Diagnostics | 35.52M |
| co.don AG | 374.13K |
| Paion AG | 278.21K |
| bioXXmed AG | 244.68K |
| MagForce AG | 122.29K |